Apollo Hospitals and Siemens Healthineers have entered a strategic research collaboration to drive innovation in artificial intelligence (AI) and advanced imaging technologies. The initiative aims to revolutionize liver disease management in India by improving patient care pathways and clinical outcomes.
Focus on AI-Powered Diagnostics
The collaboration spans quantitative ultrasound imaging and AI-driven clinical solutions. It emphasizes early diagnosis, accurate detection, and precise monitoring of liver diseases. By combining Apollo’s clinical expertise with Siemens Healthineers’ technological leadership, the partnership seeks to address the growing burden of liver disease in India.
Tackling Rising Liver Disease Burden
According to government guidelines, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is emerging as a major health concern. Previously known as NAFLD, it is now a significant cause of liver-related morbidity in the country. Challenges in accurate diagnosis and evolving disease understanding have led to underestimated prevalence, posing a major public health concern.
Leadership Insights
Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, highlighted the significance of the partnership. She stated, “Our collaboration with Siemens Healthineers is a step forward in using AI to redefine non-invasive diagnostics for liver disease.” AI-driven progression models will enable early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes.”
Hariharan Subramanian, Managing Director, Siemens Healthcare Pvt. Ltd., emphasized, “Advanced technologies will support timely and precise diagnosis, enhance disease management, and improve quality of life for patients. This joint effort addresses the unmet needs in liver disease diagnosis and treatment.”
Driving Innovation for Better Patient Care
As reported by thehindubusinessline.com, Apollo Hospitals and Siemens Healthineers have partnered to improve liver care in India. Their goal is to make diagnostics more accessible, accurate, and effective. The collaboration underscores a commitment to leveraging technology for better healthcare outcomes.
